推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with …

A Shabaik, G Lin, M Peterson… - Diagnostic …, 2011 - Wiley Online Library
The prognostic and predictive value of Her2/neu and the hormone receptors in patient with primary
or metastatic breast cancer is essential for a favorable outcome of treatment. We have been experiencing
increasing requests to test cytologic specimens for these markers in patients with ...
Related articles - All 2 versions

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

B Aktas, V Müller, M Tewes, J Zeitz… - Gynecologic …, 2011 - ncbi.nlm.nih.gov
OBJECTIVES: The expression of predictive markers including the estrogen (ER) and progesterone
receptor (PR) expression can change during the course of the disease. Therefore, reassessment
of these markers at the time of disease progression might help to optimize treatment ...

Progesterone receptor isoform-specific promoter methylation-Association of PRA methylation with worse outcome in breast cancer patients.

TN Pathiraja, PB Shetty, J Jelinek, R He… - Clinical Cancer …, 2011 - AACR
... Progesterone receptor isoform-specific promoter methylation - Updated Version
10.1158/1078-0432.CCR-10-2950 doi: Access the most recent version of this article at: ... Page
2. 1 Progesterone receptor isoform-specific promoter methylation — Association of PRA promoter ...
Related articles - All 2 versions

Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation with Worse Outcome in Breast Cancer Patients

TN Pathiraja, PB Shetty, J Jelinek, R He… - Clinical Cancer …, 2011 - AACR
Purpose: ERα and PR levels are critical determinants for breast cancer prognosis and response
to endocrine therapy. Although PR is known to be silenced by methylation of its promoter, few
studies have correlated methylation with PR levels and outcome in breast cancer. There ...
Related articles

Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer

H Anderson, M Hills, L Zabaglo… - Annals of …, 2011 - Eur Soc Med Oncology
Background: Surprisingly few data are published on the relevance of even commonly used biomarkers
of response to aromatase inhibitors (AIs) in advanced breast cancer. Here, we aim to determine
the effectiveness of AIs in that setting according to quantitative levels of estrogen receptor ...
Cited by 1 - Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451